These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14824395)

  • 1. Relationship between serum antibodies and subclinical infections with poliomyelitis virus.
    BROWN GC; AINSLIE JD
    J Exp Med; 1951 Mar; 93(3):197-205. PubMed ID: 14824395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative studies of the virus-host relationship in chimpanzees after inapparent infection with Coxsackie viruses. I. The virus carrier state and the development of neutralizing antibodies.
    MELNICK JL; KAPLAN AS
    J Exp Med; 1953 Mar; 97(3):367-400. PubMed ID: 13052807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response of patients with poliomyelitis to virus recovered from their own alimentary tract.
    STEIGMAN AJ; SABIN AB
    J Exp Med; 1949 Oct; 90(4):349-72. PubMed ID: 18140667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of homotypic neutralizing antibody in human poliomyelitis three years after infection.
    WINSSER J; SABIN AB
    J Exp Med; 1952 Nov; 96(5):477-90. PubMed ID: 13000058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement-fixing antibodies to type 2 (Lansing) poliomyelitis virus in a normal population of a subtropical area.
    GOLDBLUM N; MELNICK JL
    J Exp Med; 1952 Aug; 96(2):175-85. PubMed ID: 14955573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poliomyelitis Lansing antibodies in three population groups in Israel.
    BERNKOPF H; LEVINE S
    Bull World Health Organ; 1955; 12(4):677-85. PubMed ID: 14379004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An epidemic of paralytic poliomyelitis characterized by dual infections with poliomyelitis and Coxsackie viruses.
    MELNICK JL; KAPLAN AS; ZABIN E; CONTRERAS G; LARKUM NW
    J Exp Med; 1951 Dec; 94(6):471-92. PubMed ID: 14897994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A specific complement-fixation test for infection with poliomyelitis virus.
    CASALS J; OLITSKY PK; ANSLOW RO
    J Exp Med; 1951 Aug; 94(2):123-37. PubMed ID: 14861374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACTIVE IMMUNITY TO POLIOMYELITIS IN CHIMPANZEES FOLLOWING SUBCLINICAL INFECTION.
    Melnick JL; Horstmann DM
    J Exp Med; 1947 Feb; 85(3):287-303. PubMed ID: 19871615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of antibody in experimental poliomyelitis; reproducibility of endpoint in a mouse neutralization test with Lansing poliomyelitis virus.
    MORGAN IM
    Am J Hyg; 1947 May; 45(3):372-8. PubMed ID: 20240022
    [No Abstract]   [Full Text] [Related]  

  • 11. Development, persistence, and significance of type 2, poliomyelitis complement-fixing antibody in man.
    CASALS J; OLITSKY PK; SABIN AB
    J Exp Med; 1952 Jul; 96(1):35-53. PubMed ID: 14946327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antigenic potency of non-infectious poliomyelitis virus as determined by its liberating effect on active virus neutralized by immune serum.
    KRECH U
    J Exp Med; 1955 Mar; 101(3):331-9. PubMed ID: 13233455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of neutralizing antibodies against the three types of poliomyelitis virus during an epidemic period; the ratio of inapparent infection to clinical poliomyelitis.
    MELNICK JL; LEDINKO N
    Am J Hyg; 1953 Sep; 58(2):207-22. PubMed ID: 13080261
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus.
    DAVENPORT FM; HENNESSY AV; FRANCIS T
    J Exp Med; 1953 Dec; 98(6):641-56. PubMed ID: 13109114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological reactions of the Coxsackie viruses. I. The neutralization test; technic and application.
    MELNICK JL; LEDINKO N
    J Exp Med; 1950 Nov; 92(5):463-82. PubMed ID: 14778925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neutralization of the mouse-adapted Lansing strain of poliomyelitis virus by the serum of patients and contacts.
    BROWN GC; FRANCIS T
    J Immunol; 1947 Sep; 57(1):1-10. PubMed ID: 20264681
    [No Abstract]   [Full Text] [Related]  

  • 17. Viremia in human poliomyelitis.
    HORSTMANN DM; McCOLLUM RW; MASCOLA AD
    J Exp Med; 1954 Apr; 99(4):355-69. PubMed ID: 13152281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization test of animal sera collected in Japan against poliomyelitis virus Lansing strain.
    KITAOKA M; MIURA T
    Jpn J Med; 1951 Oct; 4(5):297-305. PubMed ID: 14927265
    [No Abstract]   [Full Text] [Related]  

  • 19. STUDIES OF THE DISTRIBUTION OF POLIOMYELITIS VIRUS : V. THE VIRUS IN FAMILIAL ASSOCIATES OF CASES.
    Brown GC; Francis T; Ainslie J
    J Exp Med; 1948 Jan; 87(1):21-7. PubMed ID: 19871696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STUDIES IN RODENT POLIOMYELITIS : I. FURTHER EXPERIMENTS WITH THE MURINE STRAIN OF SK POLIOMYELITIS VIRUS.
    Jungeblut CW; Sanders M; Feiner RR
    J Exp Med; 1942 Jun; 75(6):611-29. PubMed ID: 19871210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.